TY - JOUR
T1 - De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects
AU - Undiagnosed Diseases Network
AU - Accogli, Andrea
AU - Calabretta, Sara
AU - St-Onge, Judith
AU - Boudrahem-Addour, Nassima
AU - Dionne-Laporte, Alexandre
AU - Joset, Pascal
AU - Azzarello-Burri, Silvia
AU - Rauch, Anita
AU - Krier, Joel
AU - Fieg, Elizabeth
AU - Pallais, Juan C.
AU - Acosta, Maria T.
AU - Adams, David R.
AU - Agrawal, Pankaj
AU - Alejandro, Mercedes E.
AU - Allard, Patrick
AU - Alvey, Justin
AU - Andrews, Ashley
AU - Ashley, Euan A.
AU - Azamian, Mahshid S.
AU - Bacino, Carlos A.
AU - Bademci, Guney
AU - Baker, Eva
AU - Balasubramanyam, Ashok
AU - Baldridge, Dustin
AU - Bale, Jim
AU - Barbouth, Deborah
AU - Batzli, Gabriel F.
AU - Bayrak-Toydemir, Pinar
AU - Beggs, Alan H.
AU - Bejerano, Gill
AU - Bellen, Hugo J.
AU - Bernstein, Jonathan A.
AU - Berry, Gerard T.
AU - Bican, Anna
AU - Bick, David P.
AU - Birch, Camille L.
AU - Bivona, Stephanie
AU - Bohnsack, John
AU - Bonnenmann, Carsten
AU - Bonner, Devon
AU - Boone, Braden E.
AU - Bostwick, Bret L.
AU - Botto, Lorenzo
AU - Briere, Lauren C.
AU - Dasari, Surendra
AU - Lanpher, Brendan C.
AU - Lanza, Ian R.
AU - Morava-Kozicz, Eva
AU - Oglesbee, Devin
N1 - Funding Information:
We thank Laurens van de Wiel from the Radboud Institute for Molecular Life Sciences (Nijmegen, the Netherlands) for his assistance in calculating significance of spatial clustering of de novo variants. M.S. holds a clinician-scientist award from Fonds de Recherche du Québec Santé ( FRQS ). A.A.’s training fellowship was supported by the Mel Hoppenheim Fund in Pediatric Neurology ( Montreal Children’s Foundation ) and the Rotary Foundation (global grant GC1641420 scholarship sponsored by the Rotary district 2032, Genoa, Italy). Work performed in the M.S. laboratory was supported by funding from the Canadian Institutes of Health Research (CIHR) and Sick Kids Foundation ( NI16-028 ). Work performed in the F.C. laboratory was supported by funding from the CIHR ( FDN334023 ), the FRQS , and the Canada Foundation for Innovation (CFI 33768 ). F.C. holds the Canada Research Chair in Developmental Neurobiology. Research reported in this manuscript was in part supported by the National Institutes of Health Common Fund , through the Office of Strategic Coordination and Office of the NIH Director under award number 2U01HG007690 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Sequencing centers for subject 1 and subject 8 were the University of Washington Center for Mendelian Genomics and the Broad Institute of MIT and Harvard.
Funding Information:
We thank Laurens van de Wiel from the Radboud Institute for Molecular Life Sciences (Nijmegen, the Netherlands) for his assistance in calculating significance of spatial clustering of de novo variants. M.S. holds a clinician-scientist award from Fonds de Recherche du Québec Santé (FRQS). A.A.’s training fellowship was supported by the Mel Hoppenheim Fund in Pediatric Neurology (Montreal Children's Foundation) and the Rotary Foundation (global grant GC1641420 scholarship sponsored by the Rotary district 2032, Genoa, Italy). Work performed in the M.S. laboratory was supported by funding from the Canadian Institutes of Health Research (CIHR) and Sick Kids Foundation (NI16-028). Work performed in the F.C. laboratory was supported by funding from the CIHR (FDN334023), the FRQS, and the Canada Foundation for Innovation (CFI 33768). F.C. holds the Canada Research Chair in Developmental Neurobiology. Research reported in this manuscript was in part supported by the National Institutes of Health Common Fund, through the Office of Strategic Coordination and Office of the NIH Director under award number 2U01HG007690. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Sequencing centers for subject 1 and subject 8 were the University of Washington Center for Mendelian Genomics and the Broad Institute of MIT and Harvard.
Publisher Copyright:
© 2019 American Society of Human Genetics
PY - 2019/10/3
Y1 - 2019/10/3
N2 - Cadherins constitute a family of transmembrane proteins that mediate calcium-dependent cell-cell adhesion. The extracellular domain of cadherins consists of extracellular cadherin (EC) domains, separated by calcium binding sites. The EC interacts with other cadherin molecules in cis and in trans to mechanically hold apposing cell surfaces together. CDH2 encodes N-cadherin, whose essential roles in neural development include neuronal migration and axon pathfinding. However, CDH2 has not yet been linked to a Mendelian neurodevelopmental disorder. Here, we report de novo heterozygous pathogenic variants (seven missense, two frameshift) in CDH2 in nine individuals with a syndromic neurodevelopmental disorder characterized by global developmental delay and/or intellectual disability, variable axon pathfinding defects (corpus callosum agenesis or hypoplasia, mirror movements, Duane anomaly), and ocular, cardiac, and genital anomalies. All seven missense variants (c.1057G>A [p.Asp353Asn]; c.1789G>A [p.Asp597Asn]; c.1789G>T [p.Asp597Tyr]; c.1802A>C [p.Asn601Thr]; c.1839C>G [p.Cys613Trp]; c.1880A>G [p.Asp627Gly]; c.2027A>G [p.Tyr676Cys]) result in substitution of highly conserved residues, and six of seven cluster within EC domains 4 and 5. Four of the substitutions affect the calcium-binding site in the EC4-EC5 interdomain. We show that cells expressing these variants in the EC4-EC5 domains have a defect in cell-cell adhesion; this defect includes impaired binding in trans with N-cadherin-WT expressed on apposing cells. The two frameshift variants (c.2563_2564delCT [p.Leu855Valfs∗4]; c.2564_2567dupTGTT [p.Leu856Phefs∗5]) are predicted to lead to a truncated cytoplasmic domain. Our study demonstrates that de novo heterozygous variants in CDH2 impair the adhesive activity of N-cadherin, resulting in a multisystemic developmental disorder, that could be named ACOG syndrome (agenesis of corpus callosum, axon pathfinding, cardiac, ocular, and genital defects).
AB - Cadherins constitute a family of transmembrane proteins that mediate calcium-dependent cell-cell adhesion. The extracellular domain of cadherins consists of extracellular cadherin (EC) domains, separated by calcium binding sites. The EC interacts with other cadherin molecules in cis and in trans to mechanically hold apposing cell surfaces together. CDH2 encodes N-cadherin, whose essential roles in neural development include neuronal migration and axon pathfinding. However, CDH2 has not yet been linked to a Mendelian neurodevelopmental disorder. Here, we report de novo heterozygous pathogenic variants (seven missense, two frameshift) in CDH2 in nine individuals with a syndromic neurodevelopmental disorder characterized by global developmental delay and/or intellectual disability, variable axon pathfinding defects (corpus callosum agenesis or hypoplasia, mirror movements, Duane anomaly), and ocular, cardiac, and genital anomalies. All seven missense variants (c.1057G>A [p.Asp353Asn]; c.1789G>A [p.Asp597Asn]; c.1789G>T [p.Asp597Tyr]; c.1802A>C [p.Asn601Thr]; c.1839C>G [p.Cys613Trp]; c.1880A>G [p.Asp627Gly]; c.2027A>G [p.Tyr676Cys]) result in substitution of highly conserved residues, and six of seven cluster within EC domains 4 and 5. Four of the substitutions affect the calcium-binding site in the EC4-EC5 interdomain. We show that cells expressing these variants in the EC4-EC5 domains have a defect in cell-cell adhesion; this defect includes impaired binding in trans with N-cadherin-WT expressed on apposing cells. The two frameshift variants (c.2563_2564delCT [p.Leu855Valfs∗4]; c.2564_2567dupTGTT [p.Leu856Phefs∗5]) are predicted to lead to a truncated cytoplasmic domain. Our study demonstrates that de novo heterozygous variants in CDH2 impair the adhesive activity of N-cadherin, resulting in a multisystemic developmental disorder, that could be named ACOG syndrome (agenesis of corpus callosum, axon pathfinding, cardiac, ocular, and genital defects).
KW - ACOG
KW - CDH2
KW - N-cadherin
KW - cardiac defects
KW - cell-cell adhesion
KW - corpus callosum
KW - eye defects
KW - genital defects
KW - intellectual disability
UR - http://www.scopus.com/inward/record.url?scp=85072680859&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072680859&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2019.09.005
DO - 10.1016/j.ajhg.2019.09.005
M3 - Article
C2 - 31585109
AN - SCOPUS:85072680859
SN - 0002-9297
VL - 105
SP - 854
EP - 868
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 4
ER -